Solid phase synthesis of two cholera toxin B subunit antigens

Area of Science:

• Biochemistry
• Immunology
• Microbiology

Background:

• Cholera toxin (CT) is a protein complex responsible for cholera, a severe diarrheal disease.
• The cholera toxin beta (CTB) chain mediates toxin binding to host cell receptors.
• Identifying specific CTB regions involved in receptor interaction is crucial for developing targeted therapeutics.

Purpose of the Study:

• To synthesize specific peptide sequences of the cholera toxin beta chain.
• To investigate the immunogenicity of these synthesized peptides.
• To determine the neutralizing capacity of antibodies generated against these peptides.

Main Methods:

• Solid-phase peptide synthesis was employed to create the 30-50 and 50-75 peptide sequences of the CTB.
• Purification of synthesized peptides was achieved using gel permeation and ion exchange chromatography.
• Antibodies were generated in animal models following oral or intraperitoneal administration of the peptides.

Main Results:

• Both synthesized peptides (30-50 and 50-75) successfully induced serum antibodies that recognized the native cholera toxin.
• Antibodies generated against the 50-75 peptide demonstrated the ability to neutralize cholera toxin activity.
• Antibodies against the 30-50 peptide did not exhibit significant toxin neutralization capabilities.

Conclusions:

• The 50-75 peptide sequence of the cholera toxin beta chain contains crucial amino acids involved in toxin-receptor binding and subsequent neutralization.
• These findings contribute to understanding the structure-function relationship of cholera toxin.
• The 50-75 peptide represents a potential target for developing cholera vaccines or inhibitors.